Classification of HER2-negative breast cancers by
HER2
METABRIC
TCGA
copy number alteration
genomics
Journal
Therapeutic advances in medical oncology
ISSN: 1758-8340
Titre abrégé: Ther Adv Med Oncol
Pays: England
ID NLM: 101510808
Informations de publication
Date de publication:
2023
2023
Historique:
received:
19
04
2023
accepted:
21
09
2023
medline:
3
11
2023
pubmed:
3
11
2023
entrez:
3
11
2023
Statut:
epublish
Résumé
Recently, HER2-negative breast cancers have been reclassified by protein expression into 'HER2-low' and 'HER2-zero' subgroups, but the consideration of HER2-low breast cancer as a distinct biological subtype with differing prognoses remains controversial. By contrast, non-neutral Here, we investigated the molecular landscape of non-metastatic HER2-negative BCs in relation to Nearly two-fifths of the cohort harbored Classification of HER2-negative BCs according to
Sections du résumé
Background
UNASSIGNED
Recently, HER2-negative breast cancers have been reclassified by protein expression into 'HER2-low' and 'HER2-zero' subgroups, but the consideration of HER2-low breast cancer as a distinct biological subtype with differing prognoses remains controversial. By contrast, non-neutral
Methods
UNASSIGNED
Here, we investigated the molecular landscape of non-metastatic HER2-negative BCs in relation to
Results
UNASSIGNED
Nearly two-fifths of the cohort harbored
Conclusion
UNASSIGNED
Classification of HER2-negative BCs according to
Identifiants
pubmed: 37920257
doi: 10.1177/17588359231206259
pii: 10.1177_17588359231206259
pmc: PMC10619358
doi:
Types de publication
Journal Article
Langues
eng
Pagination
17588359231206259Informations de copyright
© The Author(s), 2023.
Références
Eur J Cancer. 2019 Oct;120:65-74
pubmed: 31493723
Genome Res. 2018 Nov;28(11):1747-1756
pubmed: 30341162
JAMA Oncol. 2022 Apr 01;8(4):1-4
pubmed: 35113160
Genome Biol. 2014;15(12):550
pubmed: 25516281
Curr Protoc. 2021 Mar;1(3):e90
pubmed: 33780170
NPJ Breast Cancer. 2021 Jan 4;7(1):1
pubmed: 33397968
Nat Commun. 2018 Sep 4;9(1):3476
pubmed: 30181556
JAMA Oncol. 2022 Aug 1;8(8):1177-1183
pubmed: 35737367
Breast Cancer. 2022 Mar;29(2):234-241
pubmed: 34622383
Breast Cancer Res. 2021 Dec 14;23(1):112
pubmed: 34906198
Bioinformatics. 2014 Apr 15;30(8):1056-1063
pubmed: 24389661
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
BMC Med. 2022 Mar 17;20(1):105
pubmed: 35296300
J Immunother Cancer. 2020 Aug;8(2):
pubmed: 32792358
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Lancet Oncol. 2021 Aug;22(8):1151-1161
pubmed: 34252375
Nat Med. 2023 Aug;29(8):2110-2120
pubmed: 37488289
Breast. 2021 Dec;60:62-69
pubmed: 34481367
Genome Biol. 2011;12(4):R41
pubmed: 21527027
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Breast Cancer Res. 2022 Mar 21;24(1):22
pubmed: 35307014
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Clin Oncol. 2018 Jul 10;36(20):2105-2122
pubmed: 29846122
Lancet Oncol. 2019 Aug;20(8):1124-1135
pubmed: 31257177
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Science. 2017 Jan 20;355(6322):
pubmed: 28104840
Br J Cancer. 1999 Aug;80(12):1968-73
pubmed: 10471047
Eur J Cancer. 2021 Sep;155:1-12
pubmed: 34311211
Cancer Res. 2004 Sep 15;64(18):6453-60
pubmed: 15374954
J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45
pubmed: 9701363
Science. 1989 May 12;244(4905):707-12
pubmed: 2470152
J Clin Oncol. 2020 Jun 10;38(17):1951-1962
pubmed: 32330069
Eur J Cancer. 2023 Jul;188:152-160
pubmed: 37247580
J Mol Diagn. 2017 Mar;19(2):244-254
pubmed: 28027945
Front Genet. 2018 Oct 01;9:421
pubmed: 30337938
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
J Clin Oncol. 2020 Jun 10;38(17):1887-1896
pubmed: 32058843
N Engl J Med. 2012 Jan 12;366(2):109-19
pubmed: 22149875
N Engl J Med. 2022 Jul 7;387(1):9-20
pubmed: 35665782
Breast Cancer Res. 2011;13(6):R129
pubmed: 22169037
Mod Pathol. 2009 Sep;22(9):1169-75
pubmed: 19448591
PLoS One. 2018 Nov 28;13(11):e0207776
pubmed: 30485330
Sci Transl Med. 2017 Mar 1;9(379):
pubmed: 28251903
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Elife. 2018 Sep 04;7:
pubmed: 30178746
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
JAMA Oncol. 2022 Apr 1;8(4):610-611
pubmed: 35113131
Clin Cancer Res. 2019 Dec 15;25(24):7413-7423
pubmed: 31515453
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153